Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
2(9%)
Results Posted
6%(1 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_4
16
70%
Ph not_applicable
3
13%
Ph phase_1
3
13%

Phase Distribution

3

Early Stage

0

Mid Stage

16

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
3(13.6%)
Phase 4Post-market surveillance
16(72.7%)
N/ANon-phased studies
3(13.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.4%

17 of 18 finished

Non-Completion Rate

5.6%

1 ended early

Currently Active

2

trials recruiting

Total Trials

23

all time

Status Distribution
Active(3)
Completed(17)
Terminated(1)
Other(2)

Detailed Status

Completed17
unknown2
Recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
2
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (13.6%)
Phase 416 (72.7%)
N/A3 (13.6%)

Trials by Status

not_yet_recruiting14%
unknown29%
completed1774%
terminated14%
recruiting29%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT06977841Not Applicable

Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial

Completed
NCT07139366Phase 4

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Recruiting
NCT07068607Phase 4

Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial

Recruiting
NCT05742568Phase 4

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Completed
NCT06514274Phase 4

Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication

Completed
NCT06168084Phase 4

Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Completed
NCT06731023

Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study

Not Yet Recruiting
NCT06603688Phase 4

Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.

Unknown
NCT05915871Phase 1

Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin

Completed
NCT05014334Phase 4

Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication

Completed
NCT04697186Phase 4

Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy

Completed
NCT04678492Phase 4

Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Completed
NCT05237115Phase 4

Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy

Completed
NCT04444011Phase 1

Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth

Unknown
NCT03609892Phase 4

Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy

Completed
NCT04066257Phase 1

Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers

Completed
NCT02159976Not Applicable

Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea

Completed
NCT02633930Phase 4

Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy

Completed
NCT00841854Phase 4

Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication

Completed
NCT02296021Phase 4

Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
23